Fri, Jul 25, 2014, 7:57 AM EDT - U.S. Markets open in 1 hr 33 mins

Recent

% | $
Click the to save as a favorite.

DARA BioSciences, Inc Message Board

  • nubu87 nubu87 Oct 4, 2013 9:50 AM Flag

    Hey Mitch

    Hi Mitch, Hey what do you think about this ??? thanks bubu DARA is focused on expanding its portfolio of oncology supportive care products in the US, via in-licensing and/or partnering of complementary late-stage and approved products. In addition, the company wishes to identify a strategic partner for the clinical development of KRN5500, currently in Phase 2 for the treatment of chronic, treatment refractory, chemotherapy induced peripheral neuropathy (CCIPN). The FDA has designated KRN5500 as a Fast Track Drug, and DARA is seeking orphan status for the treatment of CCIPN.

    Read more: http://www.nasdaq.com/press-release/dara-biosciences-sponsors-educational-programming-on-the-balancing-act-in-support-of-breast-cancer-awareness-month-20131004-00113#ixzz2glF0RQ00

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
DARA
1.41-0.08(-5.37%)Jul 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.